RLX Technology

RLXNYSE Cayman Islands Health Care Medicinal Chemicals and Botanical Products

Market cap

$1.980 B

$1.62 -1.22%

Close of 6 Nov 2026

As of 6 Nov 2026, RLX Technology (RLX) has a market capitalization of $1.98B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$566.1M

#1830 by revenue

Earnings

$131.8M

#1183 by earnings

Shares outstanding

1,548,940,307

Latest filing cover page

P/E ratio

15.0

Cap ÷ net income

Medicinal Chemicals and Botanical Products, ranked by market cap

All 26 →

#5Regencell BioscienceRGC$2.61B
#6Trulieve CannabisTRLV$2.11B
#7RLX TechnologyRLX$1.98B
#8Cronos GroupCRON$1.37B
#9Tilray BrandsTLRY$416.0M

What if RLX Technology were worth as much as…

Open the what-if tool →

Gold $28.2T

$23,102.29

Per share 14,261× higher

Bitcoin $1.53T

$1,250.02

Per share 772× higher

Apple $5.02T

$4,103.71

Per share 2,533× higher

Or at a round number

$5.00B $10.0B $20.0B $50.0B

Where these numbers come from

Share counts and financials for RLX Technology are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.